Cargando…
Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway
Microbial C1 fixation has a vast potential to support a sustainable circular economy. Hence, several biotechnologically important microorganisms have been recently engineered for fixing C1 substrates. However, reports about C1-based bioproduction with these organisms are scarce. Here, we describe th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885119/ https://www.ncbi.nlm.nih.gov/pubmed/36726742 http://dx.doi.org/10.3389/fbioe.2023.1091899 |
_version_ | 1784879862473818112 |
---|---|
author | Kim, Seohyoung Giraldo, Néstor Rainaldi, Vittorio Machens, Fabian Collas, Florent Kubis, Armin Kensy, Frank Bar-Even, Arren Lindner, Steffen N. |
author_facet | Kim, Seohyoung Giraldo, Néstor Rainaldi, Vittorio Machens, Fabian Collas, Florent Kubis, Armin Kensy, Frank Bar-Even, Arren Lindner, Steffen N. |
author_sort | Kim, Seohyoung |
collection | PubMed |
description | Microbial C1 fixation has a vast potential to support a sustainable circular economy. Hence, several biotechnologically important microorganisms have been recently engineered for fixing C1 substrates. However, reports about C1-based bioproduction with these organisms are scarce. Here, we describe the optimization of a previously engineered formatotrophic Escherichia coli strain. Short-term adaptive laboratory evolution enhanced biomass yield and accelerated growth of formatotrophic E. coli to 3.3 g-CDW/mol-formate and 6 h doubling time, respectively. Genome sequence analysis revealed that manipulation of acetate metabolism is the reason for better growth performance, verified by subsequent reverse engineering of the parental E. coli strain. Moreover, the improved strain is capable of growing to an OD(600) of 22 in bioreactor fed-batch experiments, highlighting its potential use for industrial bioprocesses. Finally, demonstrating the strain’s potential to support a sustainable, formate-based bioeconomy, lactate production from formate was engineered. The optimized strain generated 1.2 mM lactate —10% of the theoretical maximum— providing the first proof-of-concept application of the reductive glycine pathway for bioproduction. |
format | Online Article Text |
id | pubmed-9885119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98851192023-01-31 Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway Kim, Seohyoung Giraldo, Néstor Rainaldi, Vittorio Machens, Fabian Collas, Florent Kubis, Armin Kensy, Frank Bar-Even, Arren Lindner, Steffen N. Front Bioeng Biotechnol Bioengineering and Biotechnology Microbial C1 fixation has a vast potential to support a sustainable circular economy. Hence, several biotechnologically important microorganisms have been recently engineered for fixing C1 substrates. However, reports about C1-based bioproduction with these organisms are scarce. Here, we describe the optimization of a previously engineered formatotrophic Escherichia coli strain. Short-term adaptive laboratory evolution enhanced biomass yield and accelerated growth of formatotrophic E. coli to 3.3 g-CDW/mol-formate and 6 h doubling time, respectively. Genome sequence analysis revealed that manipulation of acetate metabolism is the reason for better growth performance, verified by subsequent reverse engineering of the parental E. coli strain. Moreover, the improved strain is capable of growing to an OD(600) of 22 in bioreactor fed-batch experiments, highlighting its potential use for industrial bioprocesses. Finally, demonstrating the strain’s potential to support a sustainable, formate-based bioeconomy, lactate production from formate was engineered. The optimized strain generated 1.2 mM lactate —10% of the theoretical maximum— providing the first proof-of-concept application of the reductive glycine pathway for bioproduction. Frontiers Media S.A. 2023-01-16 /pmc/articles/PMC9885119/ /pubmed/36726742 http://dx.doi.org/10.3389/fbioe.2023.1091899 Text en Copyright © 2023 Kim, Giraldo, Rainaldi, Machens, Collas, Kubis, Kensy, Bar-Even and Lindner. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Kim, Seohyoung Giraldo, Néstor Rainaldi, Vittorio Machens, Fabian Collas, Florent Kubis, Armin Kensy, Frank Bar-Even, Arren Lindner, Steffen N. Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway |
title | Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway |
title_full | Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway |
title_fullStr | Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway |
title_full_unstemmed | Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway |
title_short | Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway |
title_sort | optimizing e. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885119/ https://www.ncbi.nlm.nih.gov/pubmed/36726742 http://dx.doi.org/10.3389/fbioe.2023.1091899 |
work_keys_str_mv | AT kimseohyoung optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway AT giraldonestor optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway AT rainaldivittorio optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway AT machensfabian optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway AT collasflorent optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway AT kubisarmin optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway AT kensyfrank optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway AT barevenarren optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway AT lindnersteffenn optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway |